Toxicology of Industrial Compounds

K.J.VAN DEN BERG ET AL. 253
NATIONAL ACADEMY OF SCIENCES(NAS), 1983, Risk Assessment in Federal
Government: Managing the Process, Washington, DC. National Academic
Press.
NATIONAL RESEARCH COUNCIL (NRC), 1992, Environmental
Neurotoxicology, Washington, DC. National Academic Press.
O’CALLAGHAN, J.P., 1988, Neurotypic and gliotypic proteins as biochemical
markers of neurotoxicity, Neurotoxicol. Teratol, 10, 445–52.
O’CALLAGHAN, J.P., 1991, Quantification of glial fibrillary acidic protein:
comparison of slot-immunobinding assays with a novel sandwich ELISA,
Neurotoxicol. Teratol., 13, 275–81.
O’CALLAGHAN, J.P., 1992, Assessment of neurotoxicity using assays of neuroand
glia-localized proteins: chronology and critique, in Tilson, H. and
Mitchell, C. (Eds) Neurotoxicology, pp. 83–100. New York: Raven Press.
O’CALLAGHAN, J.P. and MILLER, D.B., 1989, Assessment of chemically-induced
alterations in brain development using assays of neuro- and glia-localized
proteins, Neurotoxicology, 10, 393–406.
O’CALLAGHAN, J.P. and JENSEN, K.F., 1992, Enhanced expression of glial
fibrillary acidic protein and the cupric silver degeneration reaction can be used
as sensitive and early indicators of neurotoxicity, Neurotoxicology, 13, 113–
22.
OORTGIESEN, M., VAN KLEEF, R. and VIJVERBERG, H.P.M., 1989, Effects Of
pyrethroids on neurotransmitter operated ion channels in cultured mouse
neuroblastoma cells, Pest. Biochem. Physiol, 34, 164–73.
PALKOVITS, M. and BROWNSTEIN, M.J., 1988, Maps and Guide to
Microdissection of the Rat Brain, New York: Elsevier.
POUNDS, J.G., 1990, The role of cell calcium in current approaches to toxicology,
Environm. Hlth Perspect., 84, 7–15.
ROGAN, W.J., GLADEN, B.C., HUNG, K.L., KOONG, S.L., SHIH, L.Y.,
TAYLOR, J.S., WU, Y.C. et al., (1988), Congenital poisoning by
polychlorinated biphenyls and their contaminants in Taiwan, Science, 241,
334–6.
ROSENGREN, L.E. and HAGLID, K.G., 1989, Long term neurotoxicity of styrene.
A quantitative study of glial fibrillary acidic protein (GFA) and S-100, Br. J.
Ind. Med., 46, 316–20.
RUSSELL, T., 1992, Environmental risk factors in Parkinson’s disease, Food
Chem. Toxicol., 30, 343–7.
SELVIN TESTA, A., LOPEZ COSTA, J.J., NESSI DE AVINON, A.C. and PECCI
SAAVEDRA, J., 1991, Astroglial alterations in rat hippocampus during
chronic lead exposure, GLIA, 4, 384–92.
SEMCHUK, K.M., LOVE, E.J. and LEE, R.G., 1993, Parkinson’s disease: a test of
the multifactorial etiologic hypothesis, Neurology, 43, 1173–80.
SICKLES, D.W., 1991, Toxic neurofilamentous axonopathies and fast anterograde
axonal transport. III. Recovery from single injections and multiple dosing
effects of acrylamide and 2,5-hexanedione, Toxicol. Appl. Pharmacol, 108,
390–6.
SIESJO, B.K. and BENGTSSON, F., 1989, Calcium fluxes, calcium antagonists,
and calcium-related pathology in brain ischemia, hypoglycemia, and spreading
depression: a unifying hypothesis, J. Cereb. Blood Flow Metab., 9, 127–140.